Anti-cancer drugs help Roche beat forecasts
Sales at drug maker Roche Holding AG climbed 17 percent in the third quarter, beating expectations, as sales of anti-cancer treatments rose strongly and fears of bird flu stoked demand for flu remedy Tamiflu.